Home / Markets / News / Granules India surges 7%, hits record high on heavy volumes

Granules India surges 7%, hits record high on heavy volumes

The trading volumes on the counter more-than-doubled with a combined 6.6 million shares changing hands on the NSE and BSE till 02:43 pm

Granules India bags exclusive rights for USpharma Windlas' four products

Premium

With the ban no longer in place, analysts at Anand Rathi Share and Stock Brokers expect growth to pick up in April-June quarter (Q1FY21) as demand for paracetamol has risen amid the Covid-19 pandemic.

SI Reporter Mumbai

2 min read Last Updated : Jul 09 2020 | 2:58 PM IST

Shares of Granules India moved higher by 7 per cent to Rs 224.70 on the BSE on Thursday on back of over two-fold jump in trading volumes. The stock of the pharmaceutical company surpassed its previous high of Rs 224.60 touched on June 16, 2020.

The trading volumes on the counter more-than-doubled with a combined 6.6 million shares changing hands on the NSE and BSE till 02:43 pm.

The company’s revenue for the quarter ended March, 2020 (Q4FY20), declined 2.2 per cent year on year (YoY) to Rs 600 crore due to restriction imposed on Paracetamol active pharmaceutical ingredients (API), pharmaceutical formulation

Topics : Granules India Buzzing stocks Markets

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in